AUA - Home - American Urological Association

AUA2026 Early-bird Deadline Approaching!

Register for the 2026 AUA Annual Meeting in Washington, DC, by February 18, 2026, to save up to $915 on your ticket to the largest gathering of urologists in the world!

Register & Save

Innovation Nexus Showcase Presenters Announced!

These 43 innovative companies from around the world have been selected to present at the 2026 AUA Innovation Nexus Forum, taking place May 14, 2026, in Washington, DC!

Explore Companies

Practice-changing, Paradigm-shifting Clinical Trials in Urology

P2s at AUA2026 are designed to showcase exceptional, groundbreaking studies that are expected to change the day-to-day practice of urology. Submissions due February 16.

Learn More

Member Advantages

A World-Class Mentorship Opportunity for Medical Students: The Boston Scientific Medical Student Innovation Fellowship supports current or matriculating medical students interested in translating urology research into innovation by engaging them in a fellowship mentored by world-class urologic scientists. Apply Now
Explore the Bladder Cancer Treatment Landscape Today: To address the documented need for additional education in bladder cancer, the American Urological Association has developed the AUA Expert Exchange Podcast Series: Bladder Cancer Treatment Landscape. Listen Now
Free Webcast Designed for APPs: Managing Male OAB: Update for the APP provides Advanced Practice Providers with practical updates on the latest strategies for managing Overactive Bladder. Stream Now
New ILB Podcast Episode: Tune in for an insightful look at what practice managers wish providers knew about revenue cycle management. Listen Now

Upcoming Events

January 2026 24

Oral Board Review Course

January 2026 29

Free Webinar: A New Treatment Approach for Cisplatin-Ineligible Patients with MIBC

February 2026 2

2026 Urology Residency Match Announced

February 2026 6

AUA Summit Section Match Program

View All Events

Latest from the Journals

JU | January 2026

Prolonged Progression-Free Survival, Disease-Free Survival, and Cystectomy Avoidance With IL-15 Receptor Lymphocyte–Stimulating Agent NAI Plus Bacillus Calmette-Guérin in Bacillus Calmette-Guérin–Unresponsive Papillary-Only Nonmuscle-Invasive Bladder Cancer

In QUILT-3.032, the efficacy of interleukin-15 receptor agonist, nogapendekin alfa inbakicept (NAI), in combination with bacillus Calmette-Guérin (BCG) for BCG-unresponsive high-grade papillary-only nonmuscle-invasive bladder cancer was assessed. In this study, we report the 36-month follow-up among participants with BCG-unresponsive papillary disease (cohort B).

View Now

Share Your Patient Story at AUA2026 in DC!

Submissions Due March 2

Open to patients, caregivers, advocates, and providers. Amplify patient voices to improve patient care, physician-patient communication, and advance health outcomes for all urologic patients.

Submit Now

UPDATE SERIES SALE

New Year, New Lessons, New Savings

Subscribe to the 2026 AUA Update Series by January 30, 2026, to save up to 20% on 40 brand new lessons in the new year!

Subscribe Now

Welcome Chuck Todd!

Introducing the 2026 Advocacy Summit Closing Keynote

Chuck Todd, former chief political analyst at NBC and moderator of Meet the Press from 2014-2023 will deliver the closing keynote address on Wednmesday, February 25. Don't miss it!

Learn More

The Advanced Prostate Cancer Clinical Trial Research Webinar Series

This video series aims to provide urologists with knowledge to successfully establish and complete clinical trial research for new and emerging therapies in the treatment of advanced prostate cancer.

Learn More